L605 Sirolimus Eluting Stent
- UID
- IMP/MD/2020/000435_8f9cb33f5dc5b712330424093ef4514c_55262dab661061eb8660275d213bc8b5
- Device class
- Class D
- Brand name
- Cobalt Chromium
- License holder
- Heartwave Medical Private Limited ,C-67, THIRD FLOOR, DDA SHEDS, OKHLA INDUSTRIAL AREA PHASE-I ,New Delhi Delhi ,110020 ,India
- Approving authority
- CDSCO
- Product information
- intended for improving luminal diameter for the treatment of de novo lesions 42mm in length in native coronary arteries > 2.5 to 4.0 mm in diameter. The summary of the indications are: • De Novo (Cobalt Chromium) • Restenosis after PTCA • Vein bypass stenosis or closure • High risk of restenosis after PTCA • Dissection after PTCA • Recoil after PTCA • Acute vascular occlusion • Sub-optimal result after PTCA • The treatment of stenoses in lesions with branch arteries
L605 Sirolimus Eluting Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000435_8f9cb33f5dc5b712330424093ef4514c_55262dab661061eb8660275d213bc8b5. This device is marketed under the brand name Cobalt Chromium. The license holder is Heartwave Medical Private Limited ,C-67, THIRD FLOOR, DDA SHEDS, OKHLA INDUSTRIAL AREA PHASE-I ,New Delhi Delhi ,110020 ,India, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.